Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 2	2024-04-05		NCT06223711

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Universität des Saarlandes	18

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Kliniken Maria Hilf	Mönchengladbach	Germany	1
Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology	Homburg	Germany	2
University Hospital Augsburg, Radiation Oncology	Augsburg	Germany	2
University Hospital Erlangen, Radiation Oncology	Erlangen	Germany	2
University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy	Regensburg	Germany	2